BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 20645101)

  • 1. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
    Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
    Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid in bone marrow smears of patients affected by multiple myeloma.
    Petruzziello F; Zeppa P; Catalano L; Cozzolino I; Gargiulo G; Musto P; D'Auria F; Liso V; Rizzi R; Caruso N; Califano C; Piro E; Musso M; Bonanno V; Pia Falcone A; Tafuto S; Di Raimondo F; De Laurentiis M; Pane F; Palombini L; Rotoli B
    Ann Hematol; 2010 May; 89(5):469-74. PubMed ID: 19894050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV; Gertz MA; Kyle RA
    Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
    Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N
    Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
    Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
    J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 cases.
    Swan N; Skinner M; O'Hara CJ
    Am J Clin Pathol; 2003 Oct; 120(4):610-6. PubMed ID: 14560572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma.
    Hirota S; Miyamoto M; Kasugai T; Kitamura Y; Morimura Y
    Arch Pathol Lab Med; 1990 Apr; 114(4):429-31. PubMed ID: 2108650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary systemic amyloidosis: three different presentations.
    Saoji V; Chaudhari S; Gohokar D
    Indian J Dermatol Venereol Leprol; 2009; 75(4):394-7. PubMed ID: 19584467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined bilateral submandibular and sublingual swelling, macroglossus, and carpal tunnel syndrome caused by light chain amyloidosis.
    Jønsson V; Rasmussen N; Juhl BR; Gimsing P; Vorstrup S
    Ear Nose Throat J; 1998 Feb; 77(2):95-8, 100-1. PubMed ID: 9509722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
    Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor.
    Vela-Ojeda J; García-Ruiz Esparza MA; Padilla-González Y; Sánchez-Cortes E; García-Chávez J; Montiel-Cervantes L; Reyes-Maldonado E; Majluf-Cruz A; Mayani H
    Ann Hematol; 2009 Jan; 88(1):59-66. PubMed ID: 18648809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
    Rago A; Grammatico S; Za T; Levi A; Mecarocci S; Siniscalchi A; De Rosa L; Felici S; Bongarzoni V; Piccioni AL; La Verde G; Pisani F; Franceschini L; Paviglianiti AL; Caravita T; Petrucci MT; De Stefano V; Cimino G;
    Cancer; 2012 Nov; 118(22):5544-9. PubMed ID: 22786730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis.
    Elad S; Czerninski R; Fischman S; Keshet N; Drucker S; Davidovich T; Goldschmidt N
    Amyloid; 2010 Mar; 17(1):27-31. PubMed ID: 20146645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].
    Adam Z; Matýková M; Krejcí M; Pour L; Kissová J; Slechtová M; Chlupová G; Stavarová Y; Simonides J; Penka M; Mayer J; Hájek R
    Vnitr Lek; 2010 Jan; 56(1):67-78. PubMed ID: 20184115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid arthropathy in the course of multiple myeloma.
    Fautrel B; Fermand JP; Sibilia J; Nochy D; Rousselin B; Ravaud P
    J Rheumatol; 2002 Jul; 29(7):1473-81. PubMed ID: 12136908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin synthesis in primary and myeloma amyloidosis.
    Preud'homme JL; Ganeval D; Grünfeld JP; Striker L; Brouet JC
    Clin Exp Immunol; 1988 Sep; 73(3):389-94. PubMed ID: 3145161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and origin of amyloid in kidney biopsies.
    von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
    Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients.
    Perfetti V; Colli Vignarelli M; Anesi E; Garini P; Quaglini S; Ascari E; Merlini G
    Haematologica; 1999 Mar; 84(3):218-21. PubMed ID: 10189385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.